Latest papers

Gallotannin inhibits NFĸB signaling and growth of human colon cancer xenografts.

Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.

Apigetrin induces erythroid differentiation of human leukemia cells K562: proteomics approach.

In vitro and in vivo evaluation of sanguinarine liposomes prepared by a remote loading method with three different ammonium salts.

Triptolide and its expanding multiple pharmacological functions.

Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBPβ expression by ERK pathway activation.

Effects of the multidrug resistance modulator HZ08 on the apoptosis pathway in human chronic leukaemia cell line K562/A02.

Effects of vincristine on the bile flow in male albino rats.

Vinflunine: a fluorinated vinca alkaloid for bladder cancer therapy.

Antitumor cyclic hexapeptides from rubia plants: history, chemistry, and mechanism (2005-2011).

[A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock].

A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines.

A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.

Glycolytic flux occurs in Drosophila melanogaster recovering from camptothecin treatment.

Isolation and characterization of cytotoxic compounds from Euphorbia cornigera Boiss.

Tephrosin-induced autophagic cell death in A549 non-small cell lung cancer cells.

In vivo modulation of 4E binding protein 1 (4E-BP1) phosphorylation by watercress: a pilot study.

[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].

Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients.

[Risk associated with severe hematological toxicity in patients with advanced or recurrent colonic cancer receiving combination chemotherapy of S-1 and irinotecan hydrochloride].